Neuberger Berman Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213M | Sell |
|
|||||
|
2025
Q1 | $277M | Sell |
|
|||||
|
2024
Q4 | $329M | Buy |
|
|||||
|
2024
Q3 | $473M | Sell |
|
|||||
|
2024
Q2 | $479M | Buy |
|
|||||
|
2024
Q1 | $435M | Sell |
|
|||||
|
2023
Q4 | $409M | Sell |
|
|||||
|
2023
Q3 | $583M | Sell |
|
|||||
|
2023
Q2 | $509M | Buy |
|
|||||
|
2023
Q1 | $566M | Buy |
|
|||||
|
2022
Q4 | $469M | Buy |
|
|||||
|
2022
Q3 | $407M | Sell |
|
|||||
|
2022
Q2 | $379M | Buy |
|
|||||
|
2022
Q1 | $417M | Sell |
|
|||||
|
2021
Q4 | $378M | Buy |
|
|||||
|
2021
Q3 | $338M | Sell |
|
|||||
|
2021
Q2 | $410M | Sell |
|
|||||
|
2021
Q1 | $357M | Buy |
|
|||||
|
2020
Q4 | $273M | Buy |
|
|||||
|
2020
Q3 | $298M | Sell |
|
|||||
|
2020
Q2 | $340M | Buy |
|
|||||
|
2020
Q1 | $240M | Buy |
|
|||||
|
2019
Q4 | $120M | Buy |
|
|||||
|
2019
Q3 | $86.3M | Sell |
|
|||||
|
2019
Q2 | $98.3M | Sell |
|
|||||
|
2019
Q1 | $129M | Buy |
|
|||||
|
2018
Q4 | $117M | Sell |
|
|||||
|
2018
Q3 | $128M | Buy |
|
|||||
|
2018
Q2 | $103M | Buy |
|
|||||
|
2018
Q1 | $102M | Buy |
|
|||||
|
2017
Q4 | $109M | Sell |
|
|||||
|
2017
Q3 | $131M | Sell |
|
|||||
|
2017
Q2 | $144M | Sell |
|
|||||
|
2017
Q1 | $113M | Sell |
|
|||||
|
2016
Q4 | $111M | Sell |
|
|||||
|
2016
Q3 | $122M | Sell |
|
|||||
|
2016
Q2 | $107M | Sell |
|
|||||
|
2016
Q1 | $110M | Sell |
|
|||||
|
2015
Q4 | $169M | Sell |
|
|||||
|
2015
Q3 | $146M | Sell |
|
|||||
|
2015
Q2 | $170M | Sell |
|
|||||
|
2015
Q1 | $157M | Sell |
|
|||||
|
2014
Q4 | $148M | Sell |
|
|||||
|
2014
Q3 | $142M | Sell |
|
|||||
|
2014
Q2 | $120M | Sell |
|
|||||
|
2014
Q1 | $133M | Sell |
|
|||||
|
2013
Q4 | $126M | Buy |
|
|||||
|
2013
Q3 | $142M | Sell |
|
|||||
|
2013
Q2 | $105M | Buy |
|